Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Phase I pharmacokinetic study
Main objective:
To determine plasmatic profiles and pharmacokinetic parameters of estradiol and progesterone
on each of the formulations studied, after multiple-dose administration
Study design:
Randomized, controlled, open-label, parallel, pharmacokinetic study
Sites: 1
Subjects: 30 postmenopausal women